ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

ACS Modifies Pap Test Guidelines

November 27, 1987

DCE Board Approves concepts For Grants to Develop HPV Animal Models, ALL Etiology Contracts

March 11, 1988

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996

Carlson Named NCCN Chief Executive

September 28, 2012